Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Mark Batshaw, MD

Executive Vice President, Physician-in-Chief & Chief Academic Officer
View My Research Profile


  • Main Hospital Washington, District of Columbia 20010 1-888-884-BEAR (2327)

Languages Spoken

  • English

Board Certifications

  • American Board of Pediatrics
  • American Board of Ped/Neurodevelop. Disabilities

National Provider ID: 1639250442



Mark Batshaw, MD, is Executive Vice President, Physician-in-Chief & Chief Academic Officer of Children's National Health System, where he also serves as director of the Children's Research Institute. He is chairman of Pediatrics and Associate Dean for Academic Affairs at the George Washington University School of Medicine and Health Sciences.  He also holds the Professorship "Fight for Children Chair in Academic Medicine."

Dr. Batshaw completed his undergraduate degree at the University of Pennsylvania and attended medical school at the University of Chicago. He completed his residency in pediatrics at the Hospital for Sick Children/University of Toronto in Toronto, Ontario, and his post-doctoral fellowship in neurodevelopmental pediatrics at the Kennedy Institute of Johns Hopkins University School of Medicine.Dr. Batshaw has spent his entire career in the care of children with developmental disabilities. His research focus is inborn errors of urea synthesis, in which he is considered an international authority in development and testing of innovative therapies. He has published more than 200 articles and reviews and is the senior editor of the classic textbook Children with Disabilities, now in its seventh edition.Dr. Batshaw lives in Washington, DC, with his wife, Karen, an international adoption social worker. They have three adult children.

Education & Training

Education & Training

  • Fellowship Program, Developmental Pediatrics, 1975
    Johns Hopkins University School of Medicine
  • Residency Program, Pediatrics, 1973
    University of Toronto
  • MD, 1971
    University of Chicago
  • BA, Natural Science, 1967
    University of Pennsylvania


Mark Batshaw

Like a Phoenix, the field of gene therapy undergoes rebirth powered by new innovations

As Dr. Batshaw passes the gavel to the next president of the American Pediatric Society during the Pediatric Academic Societies’ annual meeting, he will tell 1,000 expected attendees of his Presidential Address that “not a day goes by that I don't think of Jesse Gelsinger and his family and hope that the work our team has continued will honor him by eventually achieving success with gene therapy.” In an act of altruism, 18-year-old Jesse Gelsinger had joined the trial with the aim of helping other kids suffering from metabolic disorder.

Mark Batshaw edit

Mark L. Batshaw, MD, Receives C. Anderson Aldrich Award from American Academy of Pediatrics

Mark L. Batshaw, MD, Executive Vice President, Physician-In-Chief, and Chief Academic Officer at Children’s National Health System, received the prestigious C. Anderson Aldrich Award from the American Academy of Pediatrics (AAP) for his outstanding contributions in the field of child development and behavior. The award was presented at the AAP Section on Developmental and Behavioral Pediatrics in Washington, DC, on October 24 at the AAP National Conference and Exhibition.

Research & Publications

Research & Publications

A Pilot Study of In Vivo Liver Directed Gene Transfer With an Adenoriral Vector in Subjects with Partial Ornithine Transcarbamylase Deficiency

(2002) Gene Therapy

Brain Development and the Ontogeny of Developmental Disabilities

(2002) Advanced Pediatrics

Correction of Argininosuccinate Synthetase AS Deficiency in a Murine Model of Citrullinemia With Recombinant Adenovirus Carrying Human AS cDNA

(2000) Gene Therapy

Differences in the Human and Mouse Amino Terminal Leader Peptides of Ornithine Transcarbamylase Affect Mitochondrial Import and Efficacy of Adenoviral Vectors

(2001) Human Gene Therapy

Fatal Systemic Inflammatory Response Syndrome in a Orthinine Transcarbamylase Deficient Patient Following Adenoviral Gene Transfer

(2003) Molecular Genetics and Metabolism

LongTerm Gene Transfer to Mouse Fetuses With Recombinant Adenoviral and AdenoAssociated Virus AAV Vectors

(2000) Gene Therapy

Metabolic and Neuropsychological Phenotype in Women Heterozygous for Ornithine Transcarbamylase Deficiency

(2004) Annals of Neurology

Prospects for Prenatal Gene Therapy in Disorders Causing Mental Retardation

(2001) Mental Retardation and Developmental Disabilities Research Reviews

The Origins of Autism

(2001) Pediatric Research

Transient Depletion of CD4 Lymphocyte Improved Efficacy of Repeated Administration of Recombinant Adenovirus in the Ornithine Transcarbamylase Deficiency Sparse Fur Mice

(2000) Gene Therapy

View publications on PubMed

Invest in future cures for some of life's most devastating diseases

See other ways to give
Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you. Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you. Make it happen

Teresa Graves' Story

Teresa Graves, MSN, RN

Teresa began her career at Children’s National as a Student Nurse Child Care Technician, and, after 17 years, is now a Nurse Manager for the primary care clinics. She was recently recognized for her work in Community Nursing by Washingtonian Magazine. 

Read More of Teresa Graves' Story